key: cord-0955649-ugke5nxj
authors: Özdemir, Ahmet Kağan; Hayran, Yıldız; Şen, Orhan; Aktaş, Akın
title: Effect of COVID‐19 pandemic on psoriatic patients dermatology admissions and biologic treatment adherences: A single‐center retrospective study
date: 2021-10-11
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14512
sha: 36481da3bcab34413b62e052e55f9bdc8fac461a
doc_id: 955649
cord_uid: ugke5nxj

nan

To the Editor, about receiving treatment also changed during this period due to either healthcare access difficulties or concern on the safety of these drugs. 4, 5 In Turkey, patients were able to receive their previously prescribed biologics during EC and LC period owing to regulations for lowering hospital admissions. We think follow-up reduction was caused mainly by this regulation. Reduction of patient follow-up for all psoriatic patients may cause disease deterioration, and this may cause rise of biologic initiation as showed in our study.

Dr. Ahmet Kağan Özdemir, Dr. Yıldız Hayran, Dr. Orhan Şen, and Dr.

Akın Aktaş do not report any conflict of interest.

Ethical committee approval obtained at 11.11.2020 for E1-20-1271 numbered research.

This retrospective study is conducted with data, which is retrieved from our institutions' routine submission system; as a result, we did not obtain written informed consent from patients.

The data that support the findings of this study are available on request from the corresponding author, A.K.Ö. The data are not publicly available due to privacy of research participants. 

Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey

Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic

How does COVID-19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross-sectional survey study

Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: a single-center experience

Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic